COVID-19 Therapeutic Alert from the Chief Medical Officer 17th March 2021

Following results from the RECOVERY trial, which found convalescent plasma did not improve clinical outcomes, it is now recommended that convalescent plasma is NOT used in the management of hospitalised patients with confirmed or suspected SARS-CoV-2 infection.

Chief Medical Officer